Myomo extends, strengthens its global MyoPro patent portfolio

Myomo Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, has announced additional intellectual property protection with the issuance of new patents in the United States and Europe related to MyoPro, its unique wearable robotic brace for arm and hand paralysis.

The U.S. Patent and Trademark Office has notified the company that Patent No. 10,758,394 was issued Sept. 1. Titled “Powered Orthotic Device and Method of Using Same,” this extends the patent life on most MyoPro models through March 2039 as the protected technology now covers the use of the device for multiple joints, including a hand actuator. In addition, the European Patent Office has notified Myomo of the impending issuance of a new parallel patent covering its 38 member countries. With these patent grants, the company now has 12 patents issued worldwide, two exclusive licensed patents and nine patents pending relating to MyoPro.

Gene Tacy, Myomo’s vice president of Engineering and Manufacturing, said, “We are very proud of the ingenuity and technical skills of our engineering team, as demonstrated by receipt of these patents. Their hard work is displayed every day by the hundreds of patients whose lives have been improved by MyoPro.”

“This expansion of our global patent position solidifies our leadership as the world’s only supplier of a myoelectric powered upper limb orthosis. We are committed to protecting our intellectual property around the world in order to secure the long-term value of the MyoPro,” added Paul R. Gudonis, Myomo’s CEO. – Business Wire